Literature DB >> 23161722

Investigation of the BRAF V600E mutation by pyrosequencing in lymphoproliferative disorders.

Javier A Laurini1, Patricia Aoun, Javeed Iqbal, Wing Chan, Timothy C Greiner.   

Abstract

The presence of the BRAF c.1799T>A V600E mutation was recently described in cases of hairy cell leukemia (HCL) but not in other common lymphomas. However, many uncommon subtypes of lymphoma have not been studied. We designed a BRAF pyrosequencing assay specific for the V600E mutation, which has a sensitivity of 5% and is applicable to paraffin-embedded tissue. DNA was sequenced in 9 cases of HCL; 6 cases of variant HCL; 10 cases each of nodal marginal zone lymphoma (NMZL), extranodal marginal zone lymphoma (ENMZL), posttransplantation lymphoproliferative disorder (PTLD), and large granular lymphocyte (LGL) proliferations; 11 cases of peripheral T-cell lymphoma (PTCL); and 12 cases of anaplastic large cell lymphoma (ALCL). All (100%) cases of HCL were positive for BRAF mutations. No mutations were identified in variant HCL, NMZL, ENMZL, PTLD, PTCL, ALCL, or LGL proliferations. Among lymphoproliferative disorders, BRAF mutations are restricted to HCL.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23161722     DOI: 10.1309/AJCP5TWORA0TMXGL

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  13 in total

1.  Treatment of refractory hairy cell leukemia with a BRAF-inhibitor: lessons to be learnt.

Authors:  Eszter Sári; Zsolt György Nagy; Kornélia Baghy; Hajnalka Rajnai; Csaba Bödör; Judit Csomor; Gábor Barna; Gábor Rudas; Ilona Kovalszky; Judit Demeter
Journal:  Pathol Oncol Res       Date:  2014-05-03       Impact factor: 3.201

Review 2.  Update on the biology and treatment options for hairy cell leukemia.

Authors:  Preetesh Jain; Naveen Pemmaraju; Farhad Ravandi
Journal:  Curr Treat Options Oncol       Date:  2014-06

Review 3.  Hairy cell leukemia-new genes, new targets.

Authors:  Robert J Kreitman
Journal:  Curr Hematol Malig Rep       Date:  2013-09       Impact factor: 3.952

4.  BRAF V600E and MAP2K1 mutations in hairy cell leukemia and splenic marginal zone lymphoma cases.

Authors:  Sang-Yong Shin; Seung-Tae Lee; Hee-Jin Kim; Chang-Seok Ki; Chul Won Jung; Jong-Won Kim; Sun-Hee Kim
Journal:  Ann Lab Med       Date:  2015-02-12       Impact factor: 3.464

5.  Exome Sequencing in Classic Hairy Cell Leukaemia Reveals Widespread Variation in Acquired Somatic Mutations between Individual Tumours Apart from the Signature BRAF V(600)E Lesion.

Authors:  Nicola J Weston-Bell; Will Tapper; Jane Gibson; Dean Bryant; Yurany Moreno; Melford John; Sarah Ennis; Hanneke C Kluin-Nelemans; Andrew R Collins; Surinder S Sahota
Journal:  PLoS One       Date:  2016-02-12       Impact factor: 3.240

6.  Potential role of AKT/mTOR signalling proteins in hairy cell leukaemia: association with BRAF/ERK activation and clinical outcome.

Authors:  Eleftheria Lakiotaki; Georgia Levidou; Maria K Angelopoulou; Christos Adamopoulos; Gerassimos Pangalis; George Rassidakis; Theodoros Vassilakopoulos; Gabriella Gainaru; Pagona Flevari; Sotirios Sachanas; Angelica A Saetta; Athanasia Sepsa; Maria Moschogiannis; Christina Kalpadakis; Nikolaos Tsesmetzis; Vassilios Milionis; Ilenia Chatziandreou; Irene Thymara; Panayiotis Panayiotidis; Maria Dimopoulou; Eleni Plata; Konstantinos Konstantopoulos; Efstratios Patsouris; Christina Piperi; Penelope Korkolopoulou
Journal:  Sci Rep       Date:  2016-02-19       Impact factor: 4.379

7.  Prognosis of stage III colorectal carcinomas with FOLFOX adjuvant chemotherapy can be predicted by molecular subtype.

Authors:  Yujin Kwon; Minhee Park; Mi Jang; Seongju Yun; Won Kyu Kim; Sora Kim; Soonmyung Paik; Hyun Jung Lee; Sungpil Hong; Tae Il Kim; Byungsoh Min; Hoguen Kim
Journal:  Oncotarget       Date:  2017-06-13

8.  Hairy cell leukemia: A retrospective study on 11 patients in the Western of Iran.

Authors:  Mehrdad Payandeh; Masoud Sadeghi; Edris Sadeghi
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2015-07-01

9.  Hairy cell leukemia: short review, today's recommendations and outlook.

Authors:  V Maevis; U Mey; G Schmidt-Wolf; I G H Schmidt-Wolf
Journal:  Blood Cancer J       Date:  2014-02-14       Impact factor: 11.037

10.  High prevalence of MAP2K1 mutations in variant and IGHV4-34-expressing hairy-cell leukemias.

Authors:  Joshua J Waterfall; Evgeny Arons; Robert L Walker; Marbin Pineda; Laura Roth; J Keith Killian; Ogan D Abaan; Sean R Davis; Robert J Kreitman; Paul S Meltzer
Journal:  Nat Genet       Date:  2013-11-17       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.